Searched for
BEDAQUILINE ANTIBIOTIC
Anti-diabetes drugs and patented antivirals to get cheaper, NLEM notifiedFor the first time, patented drugs like anti-TB bedaquiline and delamanid, anti-HIV Dolutegravir and anti-hepatitis C daclatasvir are also ...- Diabetes, patented TB, HIV drugs enter essential listPopular anti-diabetes drug teneligliptin, insulin glargine injection, Common antibiotics like meropenem, Cefuroxime have been included in t...
- Essential medicines list: Govt adds 34 new drugs, drops 26; all you need to knowSeveral anti-cancer drugs, antibiotics and vaccines will now become more affordable as they are among 34 new additions to the National List...
- Several antibiotics, other drugs may get cheaperMedicines and devices listed in the NLEM must be sold at the prices set by National Pharmaceuticals Pricing Authority (NPPA), while those i...
- TB Alliance in talks with government over use of new shorter BPaL RegimenIndia has the world's highest TB burden-- 2.6 million active cases and close to 450,000 deaths each year from the infectious bacterial dise...
- BPaL regimen can cut time for treatment of drug-resistant TBBPaL is a six-month, alloral, three-drug regimen that is used to treat people with highly drug-resistant forms of TB. It consists of the TB...
- World Tuberculosis Day: TB is curable. Visit a doctor if you experience chest or joint pain, evening feverIndia alone accounts for one fourth of the global TB burden.
- FM Nirmala Sitharaman wants to eradicate TB by 2025: Know causes, symptoms & treatment of the diseaseTuberculosis is among one of the biggest risks in India, and kills 1.5 mn people every year.
- Mylan, TB Alliance seeks clinical trial waiver for Pretomanid drugPretomanid, a new oral treatment is a shorter more convenient option for people with extensively drug resistant (XDR) TB. The dossier for g...
- New treatment to be made affordable for patients: TB AlliancePretomanid is the third TB drug to have been approved by the USFDA in the last 40 years.
- USFDA okays new antibiotic for highly drug-resistant tuberculosisPretomanid, a new chemical entity, was under development since 2002 by the TB Alliance.
- Johnson and Johnson asked to cut down price of new TB drugTo ensure the drug is accessible to all, MSF called on J&J to issue a non-exclusive license to the Medicines Patent Pool to allow for price...
- Johnson and Johnson to offer first TB drug in 40 years for $900J&J said India is eligible for the lowest global price and that it is working on a sustainable access strategy.
- New J&J TB drug not without side effects: Sir John WalkerThe 1997 Nobel winner in chemistry, who was one of the speakers at the Lindau Nobel Laureates meeting, said clinical data showed that the d...
- India's dependency on charitable program for MDR TB drugs not helping, doctors sayIndia's dependency on charity from global drug makers is making it hard for patients to access new antibiotic drugs such as bedaquiline and...
- Indian scientists provide new insights for tuberculosis drug discoveryThe TB bacterium is cunning and is able to survive according to the researchers due to its ability to sense and adapt to its host's environ...
- Keen to use India's brain power, says Paul Stoffels, Chief Scientific Officer, Johnson & JohnsonStoffels, who is also worldwide chairman of the US drug major’s pharmaceuticals group, was in India recently to take stock of company’s ope...
Load More
